Clinical Trial Update: P-glycoprotein Inhibition as Adjunct Treatment for Medically Refractory Epilepsy. [Phase 2, Phase 3]

View source ↗

Summary

There is a terminated Phase 2/3 clinical trial evaluating P-glycoprotein inhibitors as adjunct therapy for medically refractory epilepsy, with results posted in…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epilepsy

Drugs mentioned

• P-glycoprotein inhibitors (class)

Snippet

Sponsor: Columbia University | Conditions: Epilepsy | Phase 2, Phase 3 | Status: TERMINATED | Results posted: 2016-04-22